MedPath
NMPA Approval

Neratinib Maleate Tablets

国药准字HJ20200009

December 31, 2024

H20200009

Drug Information

马来酸奈拉替尼片

贺俪安

片剂

40mg(按C₃₀H₂₉ClN₆O₃计)

化学药品

December 31, 2024

December 30, 2029

Company Information

Applicant Company

Puma Biotechnology

10880 Wilshire Blvd., Suite 2150, Los Angeles, CA 90024 United States of America

Manufacturing Company

Nurnberger Strasse 12, Feucht, Bayern 90537 Germany

© Copyright 2025. All Rights Reserved by MedPath
马来酸奈拉替尼片 - NMPA 批准文号 | MedPath